Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate
Links shared publicly online about this topic.
- 489total visits
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate
View full resource at drugs.com
Tags: Bipolar Disorder Medication, Schizophrenia Medication, Antipsychotic Medication, Disease and Condition, Drug, Abilify, Eskalith
Most Recently Shared on February 21, 2011 at 10:15 pm By:
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Li... http://bit.ly/fuFJIk #drug
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium | Pharmainfo.net
pharmainfo.net — “ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium | Pharmainfo.net” View full resource at pharmainfo.net
Most Recently Shared on February 25, 2011 at 1:15 am By:
Peter H Brown Doctor and Psychologist
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of ... http://bit.ly/hQ3HCe #bipolar
Abilify approved as adjunct for maintenance treatment of bipolar disorder - MPR
empr.com — “Bristol-Myers Squibb and Otsuka announced that Abilify (aripiprazole) has been approved by the FDA as an adjunct to lithium or valproate for the maintenance treatment of bipolar I disorder.” View full resource at empr.com
Most Recently Shared on February 22, 2011 at 8:04 pm By:
MPR News: Abilify approved as adjunct for maintenance treatment of bipolar disorder: Bristol-Myers Squibb and Ot... http://bit.ly/ffWVy7
Abilify approved as adjunct for maintenance treatment of bipolar disorder - ONA
oncologynurseadvisor.com — “Bristol-Myers Squibb and Otsuka announced that Abilify (aripiprazole) has been approved by the FDA as an adjunct to lithium or valproate for the maintenance treatment of bipolar I disorder.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 22, 2011 at 7:15 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Abilify approved as adjunct for maintenance treatment of bipolar disorder http://goo.gl/fb/6ZuIk
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate - Business Wire - Wire - BradentonHerald.com
bradenton.com — “Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. , announced today that the U.S. Food and Drug Administration (FDA) has approved ABILIFY ® (aripiprazole) as an adjunct to the mood stabilizers lithium or valproate for the maintenance treatment of Bipolar I Disorder.” View full resource at bradenton.com
Most Recently Shared on February 17, 2011 at 5:02 pm By:
Peter H Brown Doctor and Psychologist
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I ... http://bit.ly/fnyJ5i #bipolar
Advertisement
